Top compounds associated with response to ADGRG3


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.03 0.5
mRNA tivozanib CTRPv2 pan-cancer AAC 0.059 0.1
mRNA tivozanib GDSC1000 pan-cancer AAC 0.028 0.4
mRNA tosedostat CTRPv2 pan-cancer AAC 0.035 0.3
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.2
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.0051 0.9
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.041 0.3
mRNA triptolide CTRPv2 pan-cancer AAC -0.018 0.6
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.098 0.04
Download CSV